🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Solid Biosciences Inc.

Solid Biosciences Inc. logo
Market Cap: Low
Employees: Low

SGT-001

Solid Biosciences Inc. focuses on developing therapies for Duchenne muscular dystrophy, with lead product candidates like SGT-001 and SGT-003, and platform technologies like dual gene expression. The company is headquartered in Cambridge, Massachusetts, and collaborates with Ultragenyx Pharmaceutical Inc.

Tags: Duchenne muscular dystrophy, SGT-001, biotechnology, clinical trials, gene therapy

Website

Vision/Values | Vision/Values | Vision/Values | About | Management | Directors | About | About | About | Culture | Benefits | About | Culture | Vision/Values | Contact | Contact | About | About

Symbol: SLDB

Recent Price: $4.07

Industry: Biotechnology

CEO: Mr. Alexander G. Cumbo

Sector: Healthcare

Employees: 88

Address: 141 Portland Street, Cambridge, MA 02139

Phone: 617 337 4680

Leadership

  • Ian F. Smith, Chairman of the Board
  • Bo Cumbo, President and CEO
  • Martin Freed, M.D., F.A.C.P., Board Member
  • Ilan Ganot, Co-Founder and Strategic Advisor to the CEO
  • Clare Kahn, Ph.D., Board Member
  • Georgia Keresty, Ph.D., M.PH., Board Member
  • Sukumar Nagendran, M.D., President, Head of Research & Development, Taysha Gene Therapies
  • Adam Stone, Chief Investment Officer of Perceptive Advisors
  • Lynne Sullivan, Chief Financial Officer at Unity Biotechnology

Last updated: 2024-12-31